Jack DeHovitz, MD

Dr. Jack A. DeHovitz is Distinguished Service Professor of Medicine at the State University of New York (SUNY) Downstate Health Sciences University. His research has focused on studies examining the risk for and natural history of HIV. Dr. DeHovitz directs the Special Treatment and Research (STAR) Program, a multidisciplinary unit that links population-based research, community outreach and clinical care, employing over 100 researchers and support staff in two clinical sites. He serves or has served as co-investigator or principal investigator of research grants from NIAID, NIDA and CDC. His scholarly work has been published in the New England Journal of Medicine, JAMA, and the Annals of Internal Medicine. 

Dr. DeHovitz is a national leader in global health and co-directs SUNY’s Global Health Institute. He has developed an NIH/Fogarty-funded research training program focusing on infectious disease control in Eastern Europe and Central Asia with the University at Albany, School of Public Health and the New York State Department of Health. This program, which has worked in 11 countries in the region has provided long term training to over 110 health care researchers and faculty. 

He received his MD and MPH from the University of Texas, and completed his training in internal medicine, infectious diseases and preventive medicine at the New York Hospital-Cornell Medical Center. He has also completed a Masters in Health Care Delivery Science at Dartmouth College a joint program of the Tuck School of Business and the Dartmouth Institute. Dr. DeHovitz is a Fellow of the American College of Physicians, Infectious Diseases Society of America and the New York Academy of Medicine, and is the past District President of the Brooklyn chapter of the American College of Physicians.

Education

• Undergraduate: University of California, Davis

• Advanced Degree: University of Texas

• Medical School: University of Texas Medical Branch

• Internship: St. Vincent's Hospital and Medical Center

• Residency: The New York Hospital - Cornell Medical Center, New York

• Fellowship: Strang Fellowship in Public Health, Cornell University Medical College, NY

• Fellowship: Fellow, International Medicine (Infectious Diseases), The New York Hospital, NY

Research Interests

• HIV
• Global Health
   

• Neduzhko O, Postnov O, Perehinets I, DeHovitz J, Joseph M, Odegaard D, Kaplan R, Kiriazova T. Factors Associated with Delayed Enrollment in HIV Medical Care among HIV-Positive Individuals in Odessa Region, Ukraine. J Int Assoc Provid AIDS Care. 2017 Mar/Apr; 16:168-173. Epub 2016 Dec 30. PMID: 28034344
• Makarenko I, Ompad DC, Sazonova Y, Saliuk T, DeHovitz J, Gensburg L. Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013. J Urban Health. 2017 Feb; 94:104-114. PMID: 28097615
• Ompad DC, Wang J, Dumchev K, Barska J, Samko M, Zeziulin O, Saliuk T, Varetska O, DeHovitz J. Patterns of harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine: A two-part latent profile analysis. Int J Drug Policy. 2017 Feb 1; 43:7-15. [Epub ahead of print] PMID: 28160736
• Baxi SM, Greenblatt RM, Bacchetti P, Cohen M, DeHovitz JA, Anastos K, Gange SJ, Young MA, Aouizerat BE. Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV. Pharmacogenomics Journal. 2017 May 2. [Epub ahead of print] PMC Journal-In Process
• Park SY, Love TMT, Reynell L, Yu C, Kang TM, Anastos K, DeHovitz J, Liu C, Kober KM, Cohen M, Mack WJ, Lee HY. The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards. Scientific Reports. 2017 Aug; 1-14 [Epublished].